Tirzepatide Acetate (2023788-19-2 free base)
Tirzepatide acetate (free base CAS 2023788-19-2) is a novel dual GIP and GLP-1 receptor agonist developed for glycemic control research. It is widely used in preclinical in vitro and in vivo studies investigating metabolic diseases, including type 2 diabetes and obesity.
Product Specifications
Product Name Alternative
Glucagon Receptor, GlucagonReceptor, Tirzepatide Acetate (2023788-19-2 free base), Tirzepatide Acetate (2023788 19 2 free base), Tirzepatide Acetate (2023788192 free base)
Field of Research
Pharmacology & Drug Discovery
Purity
97.30% (May vary between batches)
Solubility
DMSO:245 mg/mL (50.27 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Molecular Weight
4873.5
Storage Conditions
Keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880096-100 1x 100 µL
Histone H1 (AE-4), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680802-500 1x 500 µL
CD35 / CR1 (CR1/802), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470646-500 1x 500 µL
Von Willebrand Factor (3E2D10 + VWF635), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740173-500 1x 500 µL
CD45 / LCA (136-4B5), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401867-500 1x 500 µL
CD8A (Cytotoxic-&Suppressor T-Cell Marker) (rC8/468), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470822-500 1x 500 µL
P21 / WAF1 (DCS-60.2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details